329 related articles for article (PubMed ID: 24588372)
1. An epidemic of contact allergy to methylisothiazolinone in Finland.
Lammintausta K; Aalto-Korte K; Ackerman L; Alanko K; Berry P; Hasan T; Kaminska R; Korhonen L; Laukkanen A; Liippo J; Pesonen M; Rantanen T; Riekki R; Suuronen K
Contact Dermatitis; 2014 Mar; 70(3):184-5. PubMed ID: 24588372
[No Abstract] [Full Text] [Related]
2. The rise in prevalence of contact allergy to methylisothiazolinone in the British Isles.
Johnston GA;
Contact Dermatitis; 2014 Apr; 70(4):238-40. PubMed ID: 24628346
[No Abstract] [Full Text] [Related]
3. Contact sensitization to methylisothiazolinone in Finland--a multicentre study.
Ackermann L; Aalto-Korte K; Alanko K; Hasan T; Jolanki R; Lammintausta K; Lauerma A; Laukkanen A; Liippo J; Riekki R; Vuorela AM; Rantanen T
Contact Dermatitis; 2011 Jan; 64(1):49-53. PubMed ID: 21166817
[TBL] [Abstract][Full Text] [Related]
4. Allergic contact dermatitis and photosensitivity to methylisothiazolinone and methylchloroisothiazolinone/methylisothiazolinone: Portrait of an epidemic in Brazil.
Villarinho ALCF; Melo MDGM; Teixeira LR
Contact Dermatitis; 2020 Apr; 82(4):258-259. PubMed ID: 31849070
[No Abstract] [Full Text] [Related]
5. Repeated open application test with methylisothiazolinone in individuals sensitive to methylchloroisothiazolinone/methylisothiazolinone.
Isaksson M; Gruvberger B; Gonçalo M; Goossens A; Le Coz CJ; Bruze M
Contact Dermatitis; 2014 Apr; 70(4):244-6. PubMed ID: 24628349
[No Abstract] [Full Text] [Related]
6. Methylisothiazolinone: the epidemic is declining - but not gone.
Urwin R; Craig S; Latheef F; Wilkinson M
Contact Dermatitis; 2017 May; 76(5):301-302. PubMed ID: 28386974
[No Abstract] [Full Text] [Related]
7. Generalized allergic contact dermatitis caused by methylisothiazolinone in a spray tan.
Madsen JT; Andersen F; Andersen KE
Contact Dermatitis; 2015 Sep; 73(3):184-5. PubMed ID: 26098619
[No Abstract] [Full Text] [Related]
8. Has the epidemic of allergic contact dermatitis due to methylisothiazolinone reached its peak?
Venables ZC; Bourke JF; Buckley DA; Campbell F; Chowdhury MMU; Abdul-Ghaffar S; Green C; Holden CR; McFadden J; Orton D; Sabroe RA; Sansom J; Stone NM; Wakelin SH; Wilkinson SM; Johnston GA
Br J Dermatol; 2017 Jul; 177(1):276-278. PubMed ID: 27579576
[No Abstract] [Full Text] [Related]
9. Outbreak of methylisothiazolinone allergy targeting those aged ≥40 years.
McFadden JP; Mann J; White JM; Banerjee P; White IR
Contact Dermatitis; 2013 Jul; 69(1):53-5. PubMed ID: 23782359
[No Abstract] [Full Text] [Related]
10. Methylisothiazolinone contact allergy - are rinse-off cosmetics and household products relevant sources of exposure?
Gallo R; Signori A; Gervasio S; Riva S; Parodi A
Contact Dermatitis; 2016 Nov; 75(5):319-321. PubMed ID: 27709703
[No Abstract] [Full Text] [Related]
11. Failures in risk assessment and risk management for cosmetic preservatives in Europe and the impact on public health.
Schwensen JF; White IR; Thyssen JP; Menné T; Johansen JD
Contact Dermatitis; 2015 Sep; 73(3):133-41. PubMed ID: 26184096
[TBL] [Abstract][Full Text] [Related]
12. Methylisothiazolinone contact allergy--growing epidemic.
Lundov MD; Opstrup MS; Johansen JD
Contact Dermatitis; 2013 Nov; 69(5):271-5. PubMed ID: 24117738
[TBL] [Abstract][Full Text] [Related]
13. Methylisothiazolinone contact allergy and dose-response relationships.
Lundov MD; Zachariae C; Johansen JD
Contact Dermatitis; 2011 Jun; 64(6):330-6. PubMed ID: 21504436
[TBL] [Abstract][Full Text] [Related]
14. The epidemic of contact allergy to methylisothiazolinone-An analysis of Danish consecutive patients patch tested between 2005 and 2019.
Havmose M; Thyssen JP; Zachariae C; Menné T; Johansen JD
Contact Dermatitis; 2021 Apr; 84(4):254-262. PubMed ID: 33043989
[TBL] [Abstract][Full Text] [Related]
15. Further evidence of the methylisothiazolinone epidemic.
Madsen JT; Andersen KE
Contact Dermatitis; 2014 Apr; 70(4):246-7. PubMed ID: 24628350
[No Abstract] [Full Text] [Related]
16. Methylisothiazolinone: second 'epidemic' of isothiazolinone sensitization.
Gameiro A; Coutinho I; Ramos L; Gonçalo M
Contact Dermatitis; 2014 Apr; 70(4):242-3. PubMed ID: 24628348
[No Abstract] [Full Text] [Related]
17. Risk factors associated with methylisothiazolinone contact sensitization.
Uter W; Geier J; Bauer A; Schnuch A
Contact Dermatitis; 2013 Oct; 69(4):231-8. PubMed ID: 23889333
[TBL] [Abstract][Full Text] [Related]
18. The dramatic increase in the rate of methylisothiazolinone contact allergy in Belgium: a multicentre study.
Aerts O; Baeck M; Constandt L; Dezfoulian B; Jacobs MC; Kerre S; Lapeere H; Pierret L; Wouters K; Goossens A
Contact Dermatitis; 2014 Jul; 71(1):41-8. PubMed ID: 24815516
[TBL] [Abstract][Full Text] [Related]
19. Contact allergy caused by methylisothiazolinone: the Belgian-French experience.
Aerts O; Goossens A; Giordano-Labadie F
Eur J Dermatol; 2015; 25(3):228-33. PubMed ID: 26412037
[TBL] [Abstract][Full Text] [Related]
20. Methylisothiazolinone, an emerging allergen in cosmetics?
García-Gavín J; Vansina S; Kerre S; Naert A; Goossens A
Contact Dermatitis; 2010 Aug; 63(2):96-101. PubMed ID: 20629674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
